ARCA Biopharma, Inc. (ABIO) - הכנסות ברוטו של החברה

סמל תאגידי ולוגו של ARCA Biopharma, Inc. (ABIO)

Developing cardiology treatments involves colossal scientific risks and intense pressure from global players. ARCA Biopharma (ABIO) revenue dynamics reflect current trends, where the value of 0.00 captures the metric level. ABIO revenues rely on the market launch of Gencaro for the therapy of atrial fibrillation. Business stability is bolstered by the dedication of the scientific team and the recruitment of specialized experts.

ABIO ARCA Bio: הכנסות החברה בטווח 04.07.2022 - 03.09.2024

פילוחי מדדים מקיפים ואנליטיקה עבור ARCA Bio (ABIO)

ניתוח מקיף של החברה:ARCA Biopharma Inc - ABIO
סחורת הדגל של ARCA Biopharma Inc

This indicator aggregates daily cash inflows from core operating activities, reflecting actual liquidity inflows bypassing accrual accounting. A time-series analysis of ARCA Biopharma (ABIO) sales allows for an assessment of revenue stability, which is based on consistent biomaterial supplies through secured contracts, helping investors distinguish the asset's true fundamental value from market noise.